| Market Cap | ₹25,893Cr |
| ROE | 22.42% |
| P/E Ratio(TTM) | 47.97 |
| EPS(TTM) | 64.43 |
| P/B Ratio | 11.92 |
| Dividend Yield | 0.77% |
| Industry P/E | 66.17 |
| Book Value | 259.37 |
| Debt to Equity | 0.07 |
| Face Value | 10 |
| Parent Organisation | Dr Lal PathLabs Limited |
| Managing Director | Dr. Om Manchanda |
| NSE Symbol | LALPATHLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Vijaya Diagnostic Centre | NA (0.00%) | 68.76 | ||
| Metropolis Healthcare | NA (0.00%) | 63.17 | ||
| Thyrocare Technologies | NA (0.00%) | 56.87 | ||
| Krsnaa Diagnostics | NA (0.00%) | 29.96 |